Literature DB >> 8396671

Transplacental transmission of a leukemogenic murine leukemia virus.

H G Bedigian1, L A Shepel, P C Hoppe.   

Abstract

Recombinant inbred BXH-2 mice spontaneously produce a B-tropic murine leukemia virus (MuLV) beginning early in life and have a high incidence of spontaneous myeloid leukemia. These traits are not characteristic of the progenitor strains (C57BL/6J and C3H/HeJ) or of 11 other recombinant inbred BXH strains. Genetic analysis has shown that the virus is not transmitted through the germ line, suggesting that the virus is passed from one generation to the next by horizontal transmission. An additional ecotropic proviral locus was detected in some mice of this strain after several generations of inbreeding. We show that BXH ecotropic virus was transmitted to other strains when fostered on viremic BXH-2 mice and that these mice go on to develop tumors of hematopoietic origin. Our earlier finding that virus is expressed early in gestation suggested that the ecotropic MuLV is also transmitted in utero. In order to determine the stage at which the ecotropic MuLV is transmitted in utero, preimplantation stage embryos were transferred to the uteri of recipient ecotropic virus-negative mice. These mice were found to be negative for the presence of the ecotropic MuLV, suggesting that transplacental transmission of the ecotropic virus readily occurs in BXH-2 mice. Although other viruses, including human lentiviruses, are transmitted across the placental barrier, transplacental transmission of MuLV is a rare event. Thus, the BXH-2 mouse strain may contribute to our understanding of the mechanism of transplacental transmission and pathogenesis and offers a potential new model for use in drug therapy of exogenously transmitted viruses related to lentiviruses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396671      PMCID: PMC238032     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Retroviruses and embryogenesis: microinjection of Moloney leukemia virus into midgestation mouse embryos.

Authors:  R Jaenisch
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

2.  High frequency germline acquisition of ecotropic MuLV proviruses in SWR/J-RF/J hybrid mice.

Authors:  N A Jenkins; N G Copeland
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

3.  Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice.

Authors:  H G Bedigian; D A Johnson; N A Jenkins; N G Copeland; R Evans
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

4.  Somatically acquired recombinant murine leukemia proviruses in thymic leukemias of AKR/J mice.

Authors:  W Herr; W Gilbert
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

5.  Structure of endogenous murine leukemia virus DNA in mouse genomes.

Authors:  S K Chattopadhyay; M R Lander; E Rands; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Germ-line reinsertions of AKR murine leukemia virus genomes in Akv-1 congenic mice.

Authors:  W P Rowe; C A Kozak
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

7.  Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice.

Authors:  N A Jenkins; N G Copeland; B A Taylor; H G Bedigian; B K Lee
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

8.  Mobility of endogenous ecotropic murine leukemia viral genomes within mouse chromosomal DNA and integration of a mink cell focus-forming virus-type recombinant provirus in the germ line.

Authors:  W Quint; H van der Putten; F Janssen; A Berns
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

9.  Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.

Authors:  T V Golovkina; A Chervonsky; J P Dudley; S R Ross
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

10.  Expression of murine leukemia viruses in the highly lymphomatous BXH-2 recombinant inbred mouse strain.

Authors:  H G Bedigian; B A Taylor; H Meier
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

View more
  7 in total

1.  The myeloid features of BXH2 leukemias may result from the lack of one copy of the repetitive sequence in the long terminal repeat viral enhancer.

Authors:  Liqun Huang; Motomi Osato; Masatoshi Yanagida; Namiko Yamashita; Yoshiaki Ito
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

2.  Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.

Authors:  B C Cho; J D Shaughnessy; D A Largaespada; H G Bedigian; A M Buchberg; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms.

Authors:  Linda Wolff; Richard Koller; Xinrong Hu; Miriam R Anver
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia.

Authors:  S M Blaydes; S C Kogan; B T Truong; D J Gilbert; N A Jenkins; N G Copeland; D A Largaespada; C I Brannan
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8.

Authors:  Jean-François Marquis; Ronald LaCourse; Lynn Ryan; Robert J North; Philippe Gros
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Evi-5, a common site of retroviral integration in AKXD T-cell lymphomas, maps near Gfi-1 on mouse chromosome 5.

Authors:  X Liao; A M Buchberg; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice.

Authors:  Karine Turcotte; Susan Gauthier; Ashleigh Tuite; Alaka Mullick; Danielle Malo; Philippe Gros
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.